• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients.

作者信息

Prediletto Irene, Farag Sarah A, Bacher Ulrike, Jeker Barbara, Mansouri Taleghani Behrouz, Brégy Rachel, Zander Thilo, Betticher Daniel, Egger Thomas, Novak Urban, Pabst Thomas

机构信息

Department of Medical Oncology, University Hospital and University of Bern, Bern, Switzerland.

Department of Hematology and Central Hematology Laboratory, University Hospital and University of Bern, Bern, Switzerland.

出版信息

Bone Marrow Transplant. 2019 Dec;54(12):1923-1925. doi: 10.1038/s41409-019-0508-2. Epub 2019 Mar 19.

DOI:10.1038/s41409-019-0508-2
PMID:30890768
Abstract
摘要

相似文献

1
High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients.在淋巴瘤和骨髓瘤患者中，基于苯达莫司汀的剂量强化大剂量化疗出现可逆性肾毒性的发生率较高。
Bone Marrow Transplant. 2019 Dec;54(12):1923-1925. doi: 10.1038/s41409-019-0508-2. Epub 2019 Mar 19.
2
Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma.苯达莫司汀在淋巴增殖性综合征和多发性骨髓瘤临床应用的建议
Eur J Haematol. 2016 May;96(5):532-40. doi: 10.1111/ejh.12633. Epub 2015 Aug 9.
3
Bendamustine: role and evidence in lymphoma therapy, an overview.苯达莫司汀：淋巴瘤治疗中的作用与证据概述
Leuk Lymphoma. 2014 Jul;55(7):1471-8. doi: 10.3109/10428194.2013.842986. Epub 2014 Feb 4.
4
The role of bendamustine in the management of plasma cell myeloma.苯达莫司汀在浆细胞骨髓瘤治疗中的作用。
Leuk Lymphoma. 2015 May;56(5):1195-6. doi: 10.3109/10428194.2014.977888. Epub 2014 Nov 19.
5
Bendamustine can be a bridge to allogeneic transplantation in relapsed Hodgkin lymphoma refractory to brentuximab vedotin.苯达莫司汀可作为复发的、对本妥昔单抗难治的霍奇金淋巴瘤进行异基因移植的桥梁。
Br J Haematol. 2017 Dec;179(5):841-843. doi: 10.1111/bjh.14257. Epub 2016 Jul 22.
6
Extended Follow-up of Patients Treated With Bendamustine for Lymphoid Malignancies.苯达莫司汀治疗淋巴系统恶性肿瘤患者的长期随访
Clin Lymphoma Myeloma Leuk. 2017 Oct;17(10):637-644. doi: 10.1016/j.clml.2017.06.033. Epub 2017 Jun 30.
7
Bendamustine in relapsed/refractory multiple myeloma: the "real-life" side of the moon.苯达莫司汀治疗复发/难治性多发性骨髓瘤：月亮的“真实一面”
Leuk Lymphoma. 2015 May;56(5):1510-3. doi: 10.3109/10428194.2014.982644. Epub 2015 Mar 3.
8
United Kingdom Myeloma Forum (UKMF) position statement on the use of bendamustine in myeloma.英国骨髓瘤论坛（UKMF）关于在骨髓瘤治疗中使用苯达莫司汀的立场声明。
Int J Lab Hematol. 2014 Feb;36(1):20-8. doi: 10.1111/ijlh.12097. Epub 2013 Apr 25.
9
Bendamustine for the treatment of multiple myeloma in first-line and relapsed-refractory settings: a review of clinical trial data.苯达莫司汀用于一线及复发难治性多发性骨髓瘤治疗：临床试验数据综述
Leuk Lymphoma. 2015 Mar;56(3):559-67. doi: 10.3109/10428194.2014.915545. Epub 2014 Jun 27.
10
Bendamustine reactivates latent Epstein-Barr virus.苯达莫司汀可重新激活潜伏的爱泼斯坦-巴尔病毒。
Leuk Lymphoma. 2016 May;57(5):1208-10. doi: 10.3109/10428194.2015.1079317. Epub 2015 Sep 15.

引用本文的文献

1
Elranatamab for Relapsed/Refractory Multiple Myeloma With Severe Renal Impairment Requiring Hemodialysis.埃兰妥单抗用于伴有严重肾功能损害且需要血液透析的复发/难治性多发性骨髓瘤
Hematol Oncol. 2025 Jul;43(4):e70120. doi: 10.1002/hon.70120.
2
Evaluation of outcome and safety profile in high-dose BEAM and Benda-EAM chemotherapy with subsequent autologous stem cell transplantation in lymphoma patients.淋巴瘤患者接受大剂量BEAM和Benda-EAM化疗并随后进行自体干细胞移植的疗效及安全性评估。
Contemp Oncol (Pozn). 2024;28(2):158-166. doi: 10.5114/wo.2024.141794. Epub 2024 Jul 26.
3
Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches.
化疗所致急性肾损伤：流行病学、病理生理学及治疗方法
Front Nephrol. 2024 Aug 9;4:1436896. doi: 10.3389/fneph.2024.1436896. eCollection 2024.
4
BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trial.苯达莫司汀-依托泊苷-阿糖胞苷方案（BendaEAM）与苯达莫司汀-阿糖胞苷方案（BEAM）作为复发淋巴瘤患者自体造血干细胞移植（ASCT）预处理方案的比较（BEB）：一项多中心、随机、2期试验
EClinicalMedicine. 2023 Nov 19;66:102318. doi: 10.1016/j.eclinm.2023.102318. eCollection 2023 Dec.
5
Safety of dendritic cell and cytokine-induced killer (DC-CIK) cell-based immunotherapy in patients with solid tumor: a retrospective study in China.基于树突状细胞和细胞因子诱导的杀伤细胞（DC-CIK）的免疫疗法在实体瘤患者中的安全性：一项中国的回顾性研究。
Am J Cancer Res. 2023 Oct 15;13(10):4767-4782. eCollection 2023.
6
Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma.曲奥舒凡与美法仑大剂量化疗治疗多发性骨髓瘤的疗效与安全性
Cancers (Basel). 2023 May 10;15(10):2699. doi: 10.3390/cancers15102699.
7
Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsing after Autologous Transplant before Availability of CAR-T Cell Treatment.在CAR-T细胞治疗可用之前接受自体移植后复发的弥漫性大B细胞淋巴瘤患者的预后
Mediterr J Hematol Infect Dis. 2023 May 1;15(1):e2023025. doi: 10.4084/MJHID.2023.025. eCollection 2023.
8
Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma.硼替佐米联合大剂量依托泊苷、阿糖胞苷、美法仑和米托蒽醌（2BeEAM）作为套细胞淋巴瘤患者自体造血干细胞移植前化疗方案的评估
Cancers (Basel). 2023 Mar 31;15(7):2091. doi: 10.3390/cancers15072091.
9
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia.在自体干细胞移植前进行包括高剂量苯达莫司汀在内的BeEAM预处理，对华氏巨球蛋白血症患者是安全有效的。
J Clin Med. 2023 Mar 19;12(6):2378. doi: 10.3390/jcm12062378.
10
BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL-A Pilot Study.弥漫性大B细胞淋巴瘤患者在自体干细胞移植前使用泊洛妥珠单抗的大剂量化疗（Pola-BeEAM）：一项试点研究
J Clin Med. 2022 Jun 28;11(13):3748. doi: 10.3390/jcm11133748.